Literature DB >> 16960652

Cerebral atrophy and white matter disruption in chronic schizophrenia.

Nicola Andreone1, Michele Tansella, Roberto Cerini, Gianluca Rambaldelli, Amelia Versace, Giovanna Marrella, Cinzia Perlini, Nicola Dusi, Luisa Pelizza, Matteo Balestrieri, Corrado Barbui, Michela Nosè, Anna Gasparini, Paolo Brambilla.   

Abstract

Several magnetic resonance imaging (MRI) studies have shown cerebral atrophy in established schizophrenia, although not in all reports. Discrepancies may mostly be due to population and postprocessing differences. Recently, disruption of cortical white matter integrity has also been reported in chronic patients with schizophrenia. In this study we explored tridimensional (3D) cerebral volumes and white matter microstructure in schizophrenia with structural and diffusion magnetic resonance. Twenty-five patients with established schizophrenia and 25 1:1 matched normal controls underwent a session of MRI using a Siemens 1.5T-scanner. 3D brain volume reconstruction was performed with the semi-automatic software Amira (TGS, San Diego, CA), whereas the apparent diffusion coefficients (ADCs) of cortical white matter water molecules were obtained with in-house developed softwares written in MatLab (The Mathworks-Inc., Natick, MA). Compared to controls, patients with schizophrenia had significantly smaller gray matter intracranium and total brain volumes, increased 4th ventricle volumes, and greater temporal and occipital ADCs. Patients treated with typical antipsychotic medication (N = 9) had significantly larger right lateral and 4th ventricles compared to those on atypical antipsychotic drugs. Intracranial volumes significantly inversely correlated with left temporal ADC in patients with schizophrenia. Also, age correlated directly with right, left, and 3rd ventricle volumes and inversely with gray matter intracranium volumes in individuals with schizophrenia. This study confirmed the presence of cortical atrophy in patients with schizophrenia, especially in those on typical antipsychotic drugs, and the existence of white matter disruption. It also suggested that physiological aging effects on brain anatomy may be abnormally pronounced in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16960652     DOI: 10.1007/s00406-006-0675-1

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  69 in total

1.  Progressive brain volume loss during adolescence in childhood-onset schizophrenia.

Authors:  Alexandra L Sporn; Deanna K Greenstein; Nitin Gogtay; Neal O Jeffries; Marge Lenane; Peter Gochman; Liv S Clasen; Jonathan Blumenthal; Jay N Giedd; Judith L Rapoport
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

2.  Integrating evaluative research and community-based mental health care in Verona, Italy.

Authors:  Michele Tansella; Lorenzo Burti
Journal:  Br J Psychiatry       Date:  2003-08       Impact factor: 9.319

Review 3.  The application of DTI to investigate white matter abnormalities in schizophrenia.

Authors:  Marek Kubicki; Carl-Fredrik Westin; Robert W McCarley; Martha E Shenton
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

4.  Prenatal determinants of schizophrenia: what we have learned thus far?

Authors:  Michaeline Bresnahan; Catherine A Schaefer; Alan S Brown; Ezra S Susser
Journal:  Epidemiol Psichiatr Soc       Date:  2005 Oct-Dec

5.  Investigation of corpus callosum in schizophrenia with diffusion imaging.

Authors:  Paolo Brambilla; Roberto Cerini; Anna Gasparini; Amelia Versace; Nicola Andreone; Enrico Vittorini; Corrado Barbui; Luisa Pelizza; Michela Nosè; Leone Barlocco; Giovanna Marrella; Manuela Gregis; Kalliopi Tournikioti; Antony S David; Matcheri S Keshavan; Michele Tansella
Journal:  Schizophr Res       Date:  2005-06-13       Impact factor: 4.939

6.  Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls.

Authors:  T D Cannon; T G van Erp; M Huttunen; J Lönnqvist; O Salonen; L Valanne; V P Poutanen; C G Standertskjöld-Nordenstam; R E Gur; M Yan
Journal:  Arch Gen Psychiatry       Date:  1998-12

7.  Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia.

Authors:  E V Sullivan; A Deshmukh; J E Desmond; D H Mathalon; M J Rosenbloom; K O Lim; A Pfefferbaum
Journal:  Arch Gen Psychiatry       Date:  2000-09

8.  Whole-brain diffusion MR histograms differ between MS subtypes.

Authors:  A O Nusbaum; C Y Tang; T Wei; M S Buchsbaum; S W Atlas
Journal:  Neurology       Date:  2000-04-11       Impact factor: 9.910

9.  Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study.

Authors:  J Burns; D Job; M E Bastin; H Whalley; T Macgillivray; E C Johnstone; S M Lawrie
Journal:  Br J Psychiatry       Date:  2003-05       Impact factor: 9.319

Review 10.  White matter changes in schizophrenia: evidence for myelin-related dysfunction.

Authors:  Kenneth L Davis; Daniel G Stewart; Joseph I Friedman; Monte Buchsbaum; Philip D Harvey; Patrick R Hof; Joseph Buxbaum; Vahram Haroutunian
Journal:  Arch Gen Psychiatry       Date:  2003-05
View more
  10 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

2.  The impact of schizophrenia on frontal perfusion parameters: a DSC-MRI study.

Authors:  Denis Peruzzo; Gianluca Rambaldelli; Alessandra Bertoldo; Marcella Bellani; Roberto Cerini; Marini Silvia; Roberto Pozzi Mucelli; Michele Tansella; Paolo Brambilla
Journal:  J Neural Transm (Vienna)       Date:  2011-01-04       Impact factor: 3.575

3.  ADC changes in schizophrenia: a diffusion-weighted imaging study.

Authors:  Igor Nenadic; Gerd Wagner; Daniel Güllmar; Claudia Schachtzabel; Katrin von Consbruch; Sabine Köhler; Kathrin Koch; Martin Roebel; C Christoph Schultz; Jürgen R Reichenbach; Heinrich Sauer; Ralf G M Schlösser
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-09-26       Impact factor: 5.270

4.  Classification of schizophrenia using feature-based morphometry.

Authors:  U Castellani; E Rossato; V Murino; M Bellani; G Rambaldelli; C Perlini; L Tomelleri; M Tansella; P Brambilla
Journal:  J Neural Transm (Vienna)       Date:  2011-09-09       Impact factor: 3.575

Review 5.  Reviewing the ketamine model for schizophrenia.

Authors:  Joel Frohlich; John D Van Horn
Journal:  J Psychopharmacol       Date:  2013-11-20       Impact factor: 4.153

Review 6.  Aging of cerebral white matter.

Authors:  Huan Liu; Yuanyuan Yang; Yuguo Xia; Wen Zhu; Rehana K Leak; Zhishuo Wei; Jianyi Wang; Xiaoming Hu
Journal:  Ageing Res Rev       Date:  2016-11-16       Impact factor: 10.895

7.  Hippocampus volume and episodic memory in schizophrenia.

Authors:  Robert J Thoma; Mollie Monnig; Faith M Hanlon; Gregory A Miller; Helen Petropoulos; Andrew R Mayer; Ron Yeo; Matt Euler; Per Lysne; Sandra N Moses; Jose M Cañive
Journal:  J Int Neuropsychol Soc       Date:  2009-02-10       Impact factor: 2.892

Review 8.  The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences.

Authors:  Hernàn Picard; Isabelle Amado; Sabine Mouchet-Mages; Jean-Pierre Olié; Marie-Odile Krebs
Journal:  Schizophr Bull       Date:  2007-06-11       Impact factor: 9.306

9.  The Clock Is Ticking - Brain Atrophy in Case of Acute Trauma?

Authors:  Alexandrina S Nikova; Georgios Sioutas; Konstantinos Kotopoulos; Dimitar Ganchev; Varvara Chatzipaulou; Theodossios Birbilis
Journal:  Korean J Neurotrauma       Date:  2019-10-23

Review 10.  Brain Structural Effects of Antidepressant Treatment in Major Depression.

Authors:  Nicola Dusi; Stefano Barlati; Antonio Vita; Paolo Brambilla
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.